New diagnostic imaging procedures in Hodgkin's disease

Annals of Oncology

Volumn 7, Issue SUPPL. 4, 1996, Pages

  Bangerter, M ^a   Griesshammer, M ^a   Binder, T ^a   Hafner, M ^a   Heimpel, H ^a   Reske, S N ^a   Frickhofen, N ^a  

^a UNIVERSITY OF ULM   (Germany)

Author keywords

Imaging procedures; Immunoscintigraphy; MRI; Positron emission tomography; Somatostatin receptor scintigraphy

Indexed keywords

SOMATOSTATIN RECEPTOR;

CANCER CLASSIFICATION; CANCER STAGING; CONFERENCE PAPER; DIAGNOSTIC ACCURACY; DIAGNOSTIC IMAGING; DISEASE ASSOCIATION; HODGKIN DISEASE; HUMAN; IMMUNOSCINTIGRAPHY; INTERMETHOD COMPARISON; NUCLEAR MAGNETIC RESONANCE IMAGING; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; TREATMENT PLANNING;

EID: 0029835961     PISSN: 09237534     EISSN: None     Source Type: Journal    
DOI: 10.1093/annonc/7.suppl_4.S55     Document Type: Conference Paper

References (25)

1. Carbone PP, Kaplan HS, Musshoff K et al. Report of the Committee on Hodgkin's disease staging classification. Cancer Res 1971;31:1860-1.
2. Kadin ME, Glatstein EJ, Dorfman RE. Clinicopathologic studies in 177 untreated patients subjected to laparotomy for the staging of Hodgkin's disease. Cancer 1971;27:1277-94.
3. Tubiana M, Henry-Amar M, Van Der Werf Messing B et al. A multivariate analysis of prognostic factors in early stage Hodgkin's disease. Int J Radiat Oncol Biol Phys 1985;11:23-30.
4. Castellino RA, Hoppe RT, Blank N et al. Computerized tomography, lymphography and staging laparotomy: Correlation in initial staging of Hodgkin's disease. AJR 1984; 143: 37-41.
5. Munker R, Hasenclever D, Brosteanu O et al. Bone marrow involvement in Hodgkin's disease: An analysis of 135 consecutive cases. J Clin Oncol 1995;13:403-9.
6. Vogler JB, Murphy WA. Bone marrow imaging. Radiology 1988;28:184-7.
7. Radford JA, Cowan RA, Flanagan M et al. The significance of residual mediastinal abnormality on the chest radiography following treatment for Hodgkin's disease. J Clin Oncol 1988;6: 940-6.
8. Reubi JC, Waser B, Van Hagen M et al. In vitro and in vivo detection of somatostatin receptors in human malignant lymphomas. Int J Cancer 1992;50:895-900.
9. Bares R, Galonska P, Dempke W et al. Somatostatin receptor scintigraphy in malignant lymphoma: First results and comparison with glucose metabolism measured by positron-emission tomography. First German Meeting, Stuttgart, 1992. Stuttgart: Georg Thieme Verlag 1993;(Suppl 27):56-8.
10. Vanhagen PM, Krenning EP, Reubi JC et al. Somatostatin analogue scintigraphy of malignant lymphomas. Br J Haematol 1993;83:75-9.
11. 111In-octreotide scintigraphy in oncology. Digestion 1993;54:84-7.
12. Skillings JR, Bramwell V, Nicholoson RL et al. A prospective study of magnetic resonance imaging in lymphoma staging. Cancer 1991;67:1838-43.
13. Weissleder R, Elizondo G, Stark DD et al. The diagnosis of splenic lymphoma by MR imaging: Value of superparamagnetic iron oxide. AJR 1989;152:175-80.
14. Hess CF, Griebel J, Schmiedl U et al. Focal lesions of the spleen: Preliminary results with fast MR imaging at 1.5 T. J Comput Assist Tomogr 1988;12:569-74.
15. Shields AF, Porter BA, Churchley S et al. The detection of bone marrow involvement by lymphoma using magnetic resonance imaging. J Clin Oncol 1987;5:225-30.
16. Linden A, Zankovich R, Theissen P et al. Malignant lymphoma: Bone marrow imaging versus biopsy. Radiology 1989; 173:335-9.
17. Olson DO, Shields AF, Scheurich CJ et al. Magnetic resonance imaging of the bone marrow in patients with leukemia, aplastic anemia, and lymphoma. Invest Radiol 1986;21:540-6.
18. Gückel F, Freund MC, Jaschke W et al. MR-Tomographie des Knochenmarks bei malignen Systemerkrankungen. Radiologie 1992;32:495-501.
19. Hoane BR, Shields AF, Porter BA et al. Detection of lymphomatous bone marrow involvement with magnetic resonance imaging. Blood 1991;78:728-38.
20. Tesoro-Tess JD, Balzarini L, Ceglia E et al. Magnetic resonance imaging in the initial staging of Hodgkin's disease and non Hodgkin lymphoma. Eur J Rad 1991;12:81-90.
21. Hill M, Cunningham D, MacVicar D et al. Role of magnetic resonance imaging in predicting relapse in residual masses after treatment of lymphoma. J Clin Oncol 1993;11:2273-8.
22. Brice P, Rain JD, Miaux Y et al. Residual mediastinal mass in malignant lymphoma: Value of magnetic resonance imaging and gallium scan. Nouv Rev Fr Hematol 1993;35:457-61.
23. Gasparini MD, Balzarini L, Castellani MR et al. Current role of gallium scan and magnetic resonance imaging in the management of mediastinal Hodgkin lymphoma. Cancer 1993; 72: 577-82.
24. Newman JS, Francis IR, Kaminski MS et al. Imaging of lymphoma with PET with 2-[F-18]-Fluoro-2-deoxy-d-glucose: Correlation with CT. Radiology 1994;190:111-6.
25. Paul R. Comparison of Fluorine-18-2-Fluorodeoxyglucose and gallium-67 citrate imaging for detection of lymphoma. J Nucl Med 1987;28:288-92.